We propose an optimized protocol for an extensive population analysis of Burkholderia cepacia and Burkholderia contaminans. Seven new polymorphisms were added to the recently proposed SNaPBcen assay, and a total of 18 markers ensured the clear identification and distinction of B. cepacia and B. contaminans isolates and high genotypic discrimination (Simpson index of 0.94) compared to those for multilocus sequence typing.
T
he Burkholderia cepacia complex (Bcc) is a very heterogeneous group of 20 bacterial species capable of adapting to an innumerable range of environments (1) . The Bcc has emerged as an important opportunistic human pathogen mainly affecting those with serious underlying conditions such as cystic fibrosis (CF) and chronic granulomatous disease (2, 3) . A major problem concerning Bcc infections is related to their intrinsic resistance to the antibiotics and biocides most frequently employed clinically, and combined therapy is often needed to treat such infections (4) (5) (6) . Bcc identification can be challenging even with selective culture media (7, 8) , a large panel of biochemical tests in routine diagnosis (9) , and automated identification systems (e.g., Vitek 2) (10). The recA gene sequence analysis currently offers better species discrimination within the Bcc (11) . Multilocus sequence typing (MLST) has also been shown to be excellent for both species identification and strain differentiation (12) , but its applicability is limited due to its high cost and time-consuming procedure. An alternative methodology, the SNaPBcen assay, which facilitates large-scale analysis of bacterial isolates, had been proposed for the identification and genotyping of B. cenocepacia (13) .
In 2009, the novel species B. contaminans and B. lata were proposed for a divergent group formerly classified as B. cepacia recA restriction fragment length polymorphism (RFLP) type K (taxon K) (14) . B. contaminans has been isolated worldwide from both environmental and clinical samples (15) (16) (17) (18) (19) (20) (21) . B. contaminans has a low prevalence in CF patients worldwide, with remarkable exceptions registered in Argentina (21), Brazil (15, 22) , Spain (23) , and Portugal (17) . The epidemiological surveillance of Bcc bacteria in respiratory infections at the major Portuguese CF center of Hospital de Santa Maria (HSM), in Lisbon, identified an exceptionally high representation of B. cepacia species isolates. This fact was attributed to contamination of saline solutions for nasal application (24) . Recently, after reexamination of the B. cepacia clinical isolates from the Institute for Bioengineering and Biosciences, Instituto Superior Técnico (iBB/IST) collection, isolates of the recA RFLP type K, formerly classified as B. cepacia species (24, 25) , and some additional isolates were classified as B. contaminans (17) .
The aim of this study was to develop a single nucleotide polymorphism (SNP)-based method for identification and genotyping of B. cepacia and B. contaminans, hereby designated the SNaPBceBcon assay. The methodology implemented allows the clear distinction of these closely related species by testing of a few molecular markers.
A total of 108 isolates of B. cepacia (n ϭ 83) and B. contaminans (n ϭ 25), obtained at the Portuguese CF treatment center at HSM, in Lisbon, including 35 isolates obtained from contaminated nonsterile saline solutions for nasal application, were used in this study (Table 1) (17, 24, 25) . The isolates had been obtained during the past 2 decades and were characterized molecularly at the iBB/ IST by sequencing analyses of the recA gene (17, (24) (25) (26) (27) . The recA PCR RFLP analysis was also performed by amplification of the entire recA gene (28) , amplicons were digested with HaeIII (Amersham Biosciences) restriction endonuclease, and the restriction fragments were separated by electrophoresis in 2% (wt/vol) agarose gels. The MLST fragments were amplified in B. cepacia and B. contaminans isolates by a multiplex reaction, as previously described (13) . The PCR conditions were slightly modified accordingly: denaturation for 15 min at 95°C; 26 cycles with denaturation for 1 min at 95°C, primer annealing for 30 s at 57°C (recA, atpD, gltB, lepA, phaC, and trpB) or 60°C (gyrB), and extension for 2 min at 72°C; and final extension for 10 min at 72°C. Before the primer annealing, touchdown PCR with three successive cycles (total of nine cycles) at increasing temperatures was performed. The strategy used for development of the SNaPBceBcon assay was similar to that previously described for B. cenocepacia (13) ; the primers are presented in Table 2 . The SNaPBceBcon assay was carried out in a final volume of 5 l, as previously described (29) . Single and multiplex reactions were compared in order to evaluate the reproducibility; molecular testing was independently performed by two researchers. Sequencing reactions were carried out for confirmation of the SNaPBceBcon assay results. Peaks were considered valid when they appeared in the correct position and presented an intensity higher than 100. For SNP selection, MLST sequences of B. cepacia (n ϭ 107) and B. contaminans (n ϭ 71) isolates available online (http://pubmlst .org/bcc/; updated November 2015) were downloaded and concatenated to an in-house record. Key polymorphic positions located at MLST genes were selected based on their ability to discriminate B. cepacia and B. contaminans strains. Eleven polymorphisms previously described for B. cenocepacia were kept on this new panel of markers in addition to 7 new polymorphisms. A final group of 18 polymorphisms were selected, presenting a final discriminatory power of 0.94 (obtained by the Simpson index) for the isolates available in the online database by comparison with the reference MLST. The SNaPBceBcon assay ensured an electrophoretic profile with 18 peaks distinguished by automated capillary electrophoresis (Fig. 1) . Electrophoretic peaks could display lower or higher intensity according to the primer affinity to the MLST sequence; isolates with sequences with high affinity to MLST genes, particularly in the primer region, tended to present taller peaks (sometimes above the graph). The novel assay was tested in a group of isolates of B. cepacia and B. contaminans obtained from clinical samples and saline solutions (Table 1) , revealing 31 distinct SNaP profiles. The species could be easily distinguished by considering the polymorphisms Gl313F, Gy338R, and 
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SNaP profile Ph318F; all isolates of B. contaminans in both the online collection and our collection showed G, T (except for 1 isolate from Brazil described in the MLST database that showed C), and G in the SNaP profiles for these positions. Some isolates with the same SNaP profiles were obtained from two or more patients (e.g., isolates IST4152, IST4162, and IST4173) ( Table 2 ). These clones found in multiple patients showed the same recA RFLP profile recurrently, as previously described (24) (25) (26) . In addition, the presence of the same SNaP profile in consecutive samples from individual patients was common in patients colonized by B. cepacia or B. contaminans, as well as the isolation of clonal variants (SNaP profiles with one or two differences) in the same patients, presumably resulting from adaptive evolution in the CF lung during chronic infection (26) . Results similar to these shown by the SNaPBceBcon assay were previously reported by MLST (16, 17, 19, 21, 25) .
The SNaPBceBcon assay represents a practical and robust alternative to the standard MLST used for B. cepacia and B. contaminans, especially in large collections. It allows the simultaneous analysis of multiple polymorphisms following amplification and minisequencing reactions. The flexibility of the method allows the modification and addition of extra markers in case they prove to be relevant for the genotyping of specific populations (30) . In this work, 7 extra markers (At66F, At248F, At359F, At443F, Gl313F, Gy218F, and Ph318F) were defined for B. cepacia and B. contaminans genotyping, in addition to 11 other markers previously defined for B. cenocepacia (13) , suggesting that a set of well-characterized markers can be used to genotype Bcc species. The proposed methodology, the SNaPBceBcon assay, was reproducible, practical, and capable of distinguishing the species B. cepacia and B. contaminans and efficiently detected the MLST profiles in our collection of isolates. The use of MLST@SNaP software (freely available online) that allows the conversion of MLST profiles into SNaP profiles and vice versa may facilitate the transference of data between the two genotyping systems (31) . An online SNP database associated with the former and the MLST database may complement and facilitate the genotyping analyses for these bacterial species.
